A metabolically healthy obese phenotype in hispanic participants in the IRAS family study

Obesity

Volumn 21, Issue 11, 2013, Pages 2303-2309

  Samaropoulos, Xanthia F ^a   Hairston, Kristen G ^a   Anderson, Andrea ^a   Haffner, Steven M ^b   Lorenzo, Carlos ^b   Montez, Maria ^b   Norris, Jill M ^c   Scherzinger, Ann L ^d   Chen, Yii Der Ida ^e   Wagenknecht, Lynne E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HISPANIC; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PHENOTYPE; PREVALENCE; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; RADIOGRAPHY; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ABDOMINAL FAT; ADULT; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEALTH; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OVERWEIGHT; PHENOTYPE; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84887185155     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20326     Document Type: Article

References (34)

1. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168 (15): 1609-1616.
2. Karelis AD,. Metabolically healthy but obese individuals. Lancet 2008; 372: 1281-1282
3. Wildman RP,. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009; 12: 438-443.
4. Muller MJ, Bosy-Westphal A, Heller M,. 'Functional' body composition: differentiating between benign and non-benign obesity. Biology Report 2009; 1: 75.
5. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P,. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043-1051.
6. Bluher M,. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 38-43.
7. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering; prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2009; 168: 1617-1624.
8. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R,. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 2010; 18 (5): 911-917.
9. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150.
10. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC,. Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 2010; 10: 1-9.
11. Fox CS, Massaro JM, Hoffman U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
12. Tarantino G, Pizza G, Colao A, et al. Hepatic steatosis in overweight/obese females: new screening method for those at risk. World J Gastroenterol 2009; 15 (45): 5693-5699.
13. Messier V, Karelis AD, Robillard ME, et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010; 59: 20-24.
14. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009; 106: 15430-15435.
15. Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S,. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity 2010; 18: 1510-1515.
16. D'Adamo E, Cali Am, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabet Care 2010; 33: 1817-1822.
17. Henkin L, Bergman RN, Bowden DW, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003; 13 (4): 211-217.
18. Wagenknecht LE, Mayer E, Rewers M, et al. The Insulin Resistance Atherosclerosis Study (IRAS): objective, design, and recruitment results. Ann Epidemiol 1995; 5: 464-472.
19. Wagenknecht LE, Scherzinger AL, Stamm ER, et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity 2009; 17 (6): 1240-1246.
20. Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28 (4): 297-302.
21. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR AM J Roentgenol 2007; 188: 1307-1312.
22. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
23. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH,. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes 2006; 30: 1529-1534.
24. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH,. Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity 2008; 16: 1602-1609.
25. Khan UI, Wang D, Thurston RC, et al. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: The Study of Women's Health Across the Nation (SWAN). Atherosclerosis 2011; 1-8.
26. Young KA, Fingerlin TE, Langefeld CD, et al. Exploring Correlates of Adiposity in Two U.S. Hispanic Populations Using Social, Behavioral and Genetic Markers: The IRAS Family Study". Ethn Dis 2012; 22 (1): 65-71.
27. Park J, Kim SH, Cho G-Y, et al. Obesity phenotype and cardiovascular changes. J Hypertens 2011; 29 (9): 1765-1772.
28. Robillard M-E, Bellefeuille P, Comtois AS, Aubertin-Leheudre M, Karelis AD,. The metabolically healthy but obese postmenopausal woman presents a favourable heart rate variability profile. Scand Cardiovasc J 2011; 45 (5): 316-320.
29. Janiszewski PM, Ross R,. Effects of weight loss among metabolically healthy obese men and women. Diabet Care 2010; 33 (9): 1957-1959.
30. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R,. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51: 1752-1754.
31. Kantarzis K, Machann J, Schick F, et al. Effects of a lifestyle intervention in metabolically benign and malignant obesity. Diabetologia 2011; 54: 864-868.
32. Bouchard DR, Langlois MF, Brochu M, Dionne IJ, Ballargeon JP,. Metabolically healthy obese women and functional capacity. Metab Syndr Relat Disord 2011; 10: 1-5.
33. Shea MK, Houston DK, Nicklas BJ, et al. The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT study. J Gerontol A Biol Sci Med Sci 2010; 65: 519-525.
34. Primeau V, Coderre L, Karelis AD,. Characterizing the profile of obese patients who are metabolically health. Int J Obes 2011; 35: 971-981.